The effect of an ICV H3-agonist on plasma prolactin in portocaval shunted and sham operated rats.
Fogel
W A
WA
Institute of Biogenic Amines, Lodz, Poland.
Tuomisto
L
L
Andrzejewski
W
W
Sasiak
K
K
Maslinski
C
C
D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006632:Histamine / Q000378:metabolism; D017442:Histamine Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D008761:Methylhistamines / Q000008:administration & dosage / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects; D011388:Prolactin / Q000097:blood*; D051381:Rats; D017208:Rats, Wistar; D018100:Receptors, Histamine H3 / Q000502:physiology*; D012701:Serotonin / Q000378:metabolism
D017442:Histamine Agonists; D006633:Histamine Antagonists; D008761:Methylhistamines; D010880:Piperidines; D018100:Receptors, Histamine H3; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; C069357:alpha-methylhistamine; D006632:Histamine; D011388:Prolactin; C052075:thioperamide; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid